Abstract
The efficacy of cyclobenzaprine 60 mg/day in the treatment of spasticity was assessed in a double-blind crossover trial of two weeks' duration in 15 patients suffering from cerebral or spinal spasticity. Independent clinical and electromyographic methods were used. The effects of cyclobenzaprine did not differ significantly from those of placebo. The administration of a higher dosage, 150 mg/day, to one patient revealed a dose-related response, but the degree of improvement was clinically small. Apart from a skin rash there were no significant untoward effects of therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burke D., Andrews C. J., Knowles L. The action of a GABA derivative in human spasticity. J Neurol Sci. 1971 Oct;14(2):199–208. doi: 10.1016/0022-510x(71)90089-x. [DOI] [PubMed] [Google Scholar]
- Burke D., Gillies J. D., Lance J. W. Hamstrings stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry. 1971 Jun;34(3):231–235. doi: 10.1136/jnnp.34.3.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burke D., Gillies J. D., Lance J. W. The quadriceps stretch reflex in human spasticity. J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):216–223. doi: 10.1136/jnnp.33.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones R. F., Burke D., Marosszeky J. E., Gillies J. D. A new agent for the control of spasticity. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):464–468. doi: 10.1136/jnnp.33.4.464. [DOI] [PMC free article] [PubMed] [Google Scholar]